Advanced Biomed Inc. Common Stock logo

Advanced Biomed Inc. Common Stock

ADVB | NASDAQ
Chart Builder DCF Calculator
$6.29
-$0.25 (-3.82%)
At close: Sep 21, 2026, 3:59 PM ET
$6.47
+$0.18 (+2.86%)
After-hours: Sep 21, 2026, 7:30 PM ET

Market Data

Market Cap
$8.94M
Enterprise Value
$6.79M
Beta
-0.36
Average Volume
1.45M
Shares Outstanding (Diluted)
1.28M
Shares Change YoY
25.49%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
US00752P2039

Price Performance

Price Change 1M
-19.1%
Price Change 3M
22.9%
Price Change 6M
47.0%
Price Change YTD
4.1%
Price Change 1Y
-30.9%
Price Change 3Y
-91.4%
Price Change 5Y
-91.4%
1M CAGR (ann.)
1.6%
1Y CAGR (ann.)
-42.6%
5Y CAGR (ann.)
N/A
All-Time CAGR
-79.2%

Valuation

PE Ratio
-29.95
Forward PE
N/A
PEG Ratio
0.04
Forward PEG
0.04
PS Ratio
N/A
Forward PS
N/A
PB Ratio
0.94
P/FCF Ratio
-12.52
P/Adj. FCF Ratio
-12.52
P/OCF Ratio
-11.65
EV/Sales
N/A
EV/EBIT
-6.38
EV/EBITDA
-6.76
EV/FCF
-9.78
Earnings Yield
-3.3%
FCF Yield
-8.0%
Adj. FCF Yield
-8.0%

Financial Health

Net Cash
$1.93M
Total Debt
$712.53K
Cash & Short-Term Investments
$2.6M
Total Assets
$10.65M
Current Ratio
7.38
Quick Ratio
7.38
Debt / Equity Ratio
0.08
Debt / EBITDA
-0.71
Debt / FCF
-1.03
OCF / Debt
-0.97
Interest Coverage
-9,783.79
Altman Z-Score
2.69
Piotroski F-Score
2

Margins & Profitability

Gross Profit Margin
0.0%
Operating Profit Margin
0.0%
EBITDA Margin
0.0%
Net Profit Margin
0.0%
FCF Margin
N/A
Adj. FCF Margin
N/A
SBC / Revenue
0.0%
SBC Impact (per share)
N/A

Returns

Return on Assets
-6.4%
Return on Equity
-20.7%
Return on Invested Capital
-11.0%
Return on Capital Employed
-11.9%
Return on Tangible Assets
-6.4%

Historical Growth (CAGR)

Revenue CAGR 3Y
N/A
Revenue CAGR 5Y
N/A
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
-30.7%
EPS CAGR 5Y
N/A
EPS CAGR 10Y
N/A
FCF CAGR 3Y
21.0%
FCF CAGR 5Y
N/A
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
0
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
May 14, 2026
EPS Estimate (next Q)
N/A
EPS Growth Est (next Q)
N/A
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Cash Flow

Operating Cash Flow
$-691.7K
Free Cash Flow
$-694.59K
Adj. Free Cash Flow
$-694.59K
FCF Per Share
-$0.54
OCF Per Share
-$0.54
OCF/S Ratio
0.0%

Income Statement

Revenue
$0
Gross Profit
$-2.84K
Operating Income
$-1.1M
EBITDA
$-1M
Net Income
$-677.61K
EPS (Diluted)
-$0.21
Revenue / Employee
N/A
Profit / Employee
$-21.86K
Employees
31

© 2026 bestshares.com. All rights reserved.